ArticleAmerican heart journal2020
Cardiac safety research consortium "shock II" think tank report: Advancing practical approaches to generating evidence for the treatment of cardiogenic shock.
Abstract readConsensus Statement
In one paragraph
Article in American heart journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Venoarterial Extracorporeal Membrane Oxygenation for Acute Massive Pulmonary Embolism: a Meta-Analysis and Call to Action.Journal of cardiovascular translational research · 2022Pooled it
- Article
- Fluid balance trajectories and prognosis in patients with acute myocardial infarction complicated by cardiogenic shock: a group-based trajectory model approach.Frontiers in cardiovascular medicine · 2025Article
- Machine learning-based prediction of mortality in acute myocardial infarction with cardiogenic shock.Frontiers in cardiovascular medicine · 2024Article
- Research Priorities in Critical Care Cardiology: JACC Expert Panel.Journal of the American College of Cardiology · 2023Review
- Treatment Intensity for the Management of Cardiogenic Shock: Comparison Between STEMI and Non-STEMI.JACC. Advances · 2023Article
- Improving Survival in Cardiogenic Shock-A Propensity Score-Matched Analysis of the Impact of an Institutional Allocation Protocol to Short-Term Mechanical Circulatory Support.Life (Basel, Switzerland) · 2022Article
- Position Statement on Vascular Access Safety for Percutaneous Devices in AMI Complicated by Cardiogenic Shock.JACC. Cardiovascular interventions · 2022Review
- Hemodynamic-based Assessment and Management of Cardiogenic Shock.US cardiology · 2022Review
- Contemporary Management of Cardiogenic Shock: A RAND Appropriateness Panel Approach.Circulation. Heart failure · 2021Article
- Review
- Blood urea nitrogen and in-hospital mortality in critically ill patients with MI or cardiogenic shock: Analysis of the MIMIC-IV database.JRSM cardiovascular diseaseArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
29 authors.
Marc D SamskyDuke University Medical Center, Duke Clinical Research Institute, Durham Veterans Administration, Durham, NC. Electronic address: marc.samsky@duke.edu.
Mitchell W KrucoffDuke University Medical Center, Cardiovascular Devices Unit, eECG Core Laboratories, Duke Clinical Research Institute, Durham, NC. Electronic address: mitchell.krucoff@duke.edu.
David A MorrowCardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. Electronic address: DMORROW@BWH.HARVARD.EDU.
William T AbrahamDivision of Cardiovascular Medicine, The Ohio State University, Columbus, OH. Electronic address: william.abraham@osumc.edu.
Fernando AguelU.S. Food and Drug Administration, CDRH/OPEQ/Office of Clinical Evidence and Analysis, Silver Spring, MD. Electronic address: fernando.aguel@fda.hhs.gov.
Andrew D AlthouseCenter for Research on Healthcare Data Center (CRHC-DC), Center for Clinical Trials & Data Coordination (CCDC), Division of General Internal Medicine, University of Pittsburgh School of Medicine, Circulation: Cardiovascular Interventions, Pittsburgh, PA. Electronic address: althousead@upmc.edu.
Eric ChenAbbott, Chicago, IL. Electronic address: eric.chen1@abbott.com.
Joaquin E CigarroaDivision of Cardiology, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR. Electronic address: cigarroa@ohsu.edu.
Adam D DeVoreDuke University Medical Center, Duke Clinical Research Institute, Durham Veterans Administration, Durham, NC. Electronic address: adam.devore@duke.edu.
Andrew FarbU.S. Food and Drug Administration, CDRH/OPEQ/Office of Clinical Evidence and Analysis, Silver Spring, MD.
Ian C GilchristPennsylvania State University, Heart and Vascular Institute, Hershey, PA. Electronic address: icg1@psu.edu.
Timothy D HenryThe Carl and Edyth Lindner Center for Research and Education at The Christ Hospital, The Carl and Edyth Lindner Family Distinguished Chair in Clinical Research, The Christ Hospital Health Network, Cincinnati, OH. Electronic address: Tim.Henry@thechristhospital.com.
Judith S HochmanNYU-HHC Clinical and Translational Science Institute, New York University School of Medicine, NYU Langone Health, New York, NY. Electronic address: Judith.Hochman@nyulangone.org.
Navin K KapurThe CardioVascular Center, Tufts Medical Center Boston, MA. Electronic address: nkapur@tuftsmedicalcenter.org.
Valarie MorrowDuke Clinical Research Institute, Durham, NC. Electronic address: valarie.morrow@duke.edu.
E Magnus OhmanDuke Program for Advanced Coronary Disease, Department of Medicine, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC. Electronic address: erik.ohman@duke.edu.
William W O'NeillCenter for Structural Heart Disease, Division of Cardiology, Henry Ford Health System, Detroit, MI. Electronic address: WONEILL1@hfhs.org.
Ileana L PiñaU.S. Food and Drug Administration, CDRH/OPEQ/Office of Clinical Evidence and Analysis, Silver Spring, MD. Electronic address: ileana.pina@fda.hhs.gov.
Alastair G ProudfootDepartment of Perioperative Medicine, St. Bartholomew's Hospital, London, United Kingdom. Electronic address: Alastair.Proudfoot@bartshealth.nhs.uk.
John S SapirsteinU.S. Food and Drug Administration, CDRH/OPEQ/Office of Clinical Evidence and Analysis, Silver Spring, MD. Electronic address: John.Sapirstein@fda.hhs.gov.
Jonathan H SeltzerWCG-ACI Clinical, Bala Cynwyd, PA. Electronic address: jseltzer@aciclinical.com.
Fred SenatoreU.S. Food and Drug Administration, CDRH/OPEQ/Office of Clinical Evidence and Analysis, Silver Spring, MD. Electronic address: fortunato.senatore@fda.hhs.gov.
Meir ShinnarU.S. Food and Drug Administration, CDRH/OPEQ/Office of Clinical Evidence and Analysis, Silver Spring, MD. Electronic address: Meir.Shinnar@fda.hhs.gov.
Charles A SimontonAbiomed, Danvers, MA. Electronic address: csimonton@abiomed.com.
Behnam N TehraniVirginia Heart, INOVA Heart and Vascular Institute, Alexandria, VA. Electronic address: behnamtehrani3@gmail.com.
Holger ThieleHeart Center Leipzig at University of Leipzig, Department of Internal Medicine/Cardiology Leipzig, Germany, Leipzig Heart Institute, Leipzig, Germany. Electronic address: holger.thiele@medizin.uni-leipzig.de.
Alexander G TruesdellVirginia Heart, INOVA Heart and Vascular Institute, Alexandria, VA. Electronic address: agtruesdell@gmail.com.
Ron WaksmanSection of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC. Electronic address: ronwaksman@gmail.com.
Sunil V RaoDuke University Medical Center, Duke Clinical Research Institute, Durham Veterans Administration, Durham, NC. Electronic address: sunil.rao@duke.edu.
Funding
Postdoctoral Training in Cardiovascular Clinical ResearchT32HL069749 · NHLBI · DUKE UNIVERSITY · PI MARK, DANIEL B · 2003 to 2023
$6.7MNHLBI NIH HHS T32 HL069749
Abstract
PubMed holds no abstract for this paper.
Indexed as
Evidence-Based MedicineHeart-Assist DevicesCardiac Care FacilitiesConsensusHealth ResourcesHospitals, High-VolumeHumansNeeds AssessmentRisk AssessmentShock, CardiogenicTherapeutic Equipoise
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.